Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing in prevalence of cardiovascular diseases
3.2.1.2 Growing technological advancement
3.2.1.3 Rising prevalence of hypertension
3.2.1.4 Favorable reimbursement scenario
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost associated with surgery procedures
3.2.2.2 Complications associated with the surgery
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Future market trends
3.7 Gap analysis
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Grafts
5.2.1 Saphenous vein grafts
5.2.2 Internal thoracic artery grafts
5.2.3 Other grafts
5.3 Retractors
5.4 Heart positioners
5.5 Tissue stabilizers
5.6 Other products
Chapter 6 Market Estimates and Forecast, By Method, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Traditional (on-pump) CABG
6.3 Minimally invasive direct CABG
6.3.1 Off-pump CABG
6.3.2 Keyhole CABG
6.3.3 Other minimally invasive CABG surgeries
Chapter 7 Market Estimates and Forecast, By Surgery Type, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Single CABG surgery
7.3 Double CABG surgery
7.4 Triple CABG surgery
7.5 Quadruple CABG surgery
Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Cardiology centers
8.4 Other end users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 AngioDynamics
10.3 AtriCure
10.4 B. Braun Melsungen AG
10.5 Boston Scientific
10.6 Cardinal Health
10.7 CryoLife
10.8 Edwards Lifesciences
10.9 Johnson & Johnson
10.10 LivaNova
10.11 Medline Industries
10.12 Medtronic
10.13 Nipro Corporation
10.14 Stryker Corporation
10.15 Terumo Corporation
